Evidence map›Paper›PMID 27559393›Full record

ArticleBeilstein journal of organic chemistry2016

Discovery of an inhibitor of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells.

Bernardas Morkunas, Balint Gal, Warren R J D Galloway, James T Hodgkinson, Brett M Ibbeson, Yaw Sing Tan, Martin Welch, David R Spring

Open access · diamondAbstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Growing emergence of drug-resistantIranian journal of basic medical sciences · 2021
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Capsaicin inhibitory effects onAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Bernardas MorkunasDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, UK.
Balint GalDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK.
Warren R J D GallowayDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK.
James T HodgkinsonDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK.
Brett M IbbesonDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK.
Yaw Sing TanDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK; Bioinformatics Institute, ASTAR, 30 Biopolis Street, #07-01 Matrix, Singapore 138671.
Martin WelchDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, UK.
David R SpringDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, UK.
University of Cambridge · GBAgency for Science, Technology and Research · SG

Funding

European Research Council 279337
6 · The paper itself

Abstract

Pyocyanin is a small molecule produced by Pseudomonas aeruginosa that plays a crucial role in the pathogenesis of infections by this notorious opportunistic pathogen. The inhibition of pyocyanin production has been identified as an attractive antivirulence strategy for the treatment of P. aeruginosa infections. Herein, we report the discovery of an inhibitor of pyocyanin production in cultures of wild-type P. aeruginosa which is based around a 4-alkylquinolin-2(1H)-one scaffold. To the best of our knowledge, this is the first reported example of pyocyanin inhibition by a compound based around this molecular framework. The compound may therefore be representative of a new structural sub-class of pyocyanin inhibitors, which could potentially be exploited in in a therapeutic context for the development of critically needed new antipseudomonal agents. In this context, the use of wild-type cells in this study is notable, since the data obtained are of direct relevance to native situations. The compound could also be of value in better elucidating the role of pyocyanin in P. aeruginosa infections. Evidence suggests that the active compound reduces the level of pyocyanin production by inhibiting the cell-cell signalling mechanism known as quorum sensing. This could have interesting implications; quorum sensing regulates a range of additional elements associated with the pathogenicity of P. aeruginosa and there is a wide range of other potential applications where the inhibition of quorum sensing is desirable.

Indexed as

antibacterialantivirulencePseudomonas aeruginosapyocyaninquorum sensing

Identifiers

PMID27559393
PMCPMC4979876
OpenAlexW2467709160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.